Share on StockTwits

BTG plc (LON:BTG) was upgraded by equities research analysts at Jefferies Group to a “buy” rating in a research note issued to investors on Tuesday. The firm currently has a GBX 760 ($12.91) target price on the stock, up from their previous target price of GBX 525 ($8.91). Jefferies Group’s price objective points to a potential upside of 25.21% from the company’s current price.

Shares of BTG plc (LON:BTG) traded up 2.10% on Tuesday, hitting GBX 607.00. The stock had a trading volume of 744,334 shares. BTG plc has a 1-year low of GBX 363.00 and a 1-year high of GBX 665.00. The stock has a 50-day moving average of GBX 621.6 and a 200-day moving average of GBX 584.0. The company’s market cap is £2.190 billion.

Several other analysts have also recently commented on the stock. Analysts at Deutsche Bank reiterated a “buy” rating on shares of BTG plc in a research note on Thursday, July 17th. They now have a GBX 655 ($11.12) price target on the stock. Separately, analysts at N+1 Singer reiterated a “sell” rating on shares of BTG plc in a research note on Wednesday, July 16th. They now have a GBX 486 ($8.25) price target on the stock. Finally, analysts at Panmure Gordon reiterated a “buy” rating on shares of BTG plc in a research note on Wednesday, July 16th. They now have a GBX 670 ($11.38) price target on the stock. Three research analysts have rated the stock with a sell rating, one has issued a hold rating and six have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of GBX 566.25 ($9.62).

BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.